Valeant to buy Egyptian drugmaker Amoun for about $800 million

>

Valeant said it expects the acquisition of privately held Amoun to help expand in Middle East and North Africa.

The deal also includes additional contingent payments, the company said in a statement.

(Reporting by Vidya L Nathan in Bengaluru; Editing by Don Sebastian)